ChatGPT-Supported Text Messaging Program for Smoking Cessation
ConditionSmoking Cessation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeorge Washington University
About this trial
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
lives in the US
smoked a cigarette within the last 7 days
has a mobile phone
willing to receive text messages about the health effects of smoking on their mobile phone for 30 days
Disqualifiers
none
Trial design
Design model
Parallel
Treatments tested in this trial
BeFree+Bot
BehavioralText messaging program called BeFree and access to BBot, ChatGPT chatbot
BeFree
BehavioralText messaging program called BeFree
Treatment groups
180 Participants
are divided into 2 treatment groupsGroup A: InterventionExperimental treatment 1 intervention
Group B: ControlActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Continuous abstinence
the longest continuous period (in days) that you did not smoke a cigarette
Time frame
at 1 month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: